Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group
CLINICAL AND TRANSLATIONAL ONCOLOGY, vol.1, pp.1-12, 2026 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 1
- Publication Date: 2026
- Doi Number: 10.1007/s12094-026-04228-5
- Journal Name: CLINICAL AND TRANSLATIONAL ONCOLOGY
- Journal Indexes: Scopus, Science Citation Index Expanded (SCI-EXPANDED), EMBASE, MEDLINE, DIALNET
- Page Numbers: pp.1-12
- Kütahya Health Sciences University Affiliated: Yes